Market revenue in 2023 | USD 1,742.7 million |
Market revenue in 2030 | USD 2,689.8 million |
Growth rate | 6.4% (CAGR from 2023 to 2030) |
Largest segment | Tablets |
Fastest growing segment | Capsules |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Tablets, Capsules, Powders, Granules |
Key market players worldwide | Catalent Inc, Lonza Group Ltd, Boehringer Ingelheim, Jubilant Pharmova, Novacyt SA, Thermo Fisher Scientific Inc, Recipharm, CordenPharma, Siegfried Holding AG, Piramal Pharma Solutions, AbbVie Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to oral solid dosage contract manufacturing market will help companies and investors design strategic landscapes.
Tablets was the largest segment with a revenue share of 32.09% in 2023. Horizon Databook has segmented the Germany oral solid dosage contract manufacturing market based on tablets, capsules, powders, granules covering the revenue growth of each sub-segment from 2018 to 2030.
Germany oral solid dosage contract manufacturing market held the highest market share of 21.6% in 2023. The increase in pharmaceutical development by CROs/CMOs in the region is a major factor responsible for market growth.
Advancements in quality oral solid drug production are some of the primary factors expected to propel the market growth over the forecast period. In addition, an increase in R&D expenditure due to highly sensitive and regulated development of pharmaceuticals is anticipated to aid in revenue generation in this country.
Horizon Databook provides a detailed overview of country-level data and insights on the Germany oral solid dosage contract manufacturing market , including forecasts for subscribers. This country databook contains high-level insights into Germany oral solid dosage contract manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account